Progression of arterial stiffness is associated with changes in bone mineral markers in advanced CKD
Arterial stiffness is an independent predictor of all-cause and cardiovascular mortality in patients with chronic kidney disease (CKD). There are limited prospective data however on progression of arterial stiffness in CKD, including evaluating associations with bone mineral markers such as fibrobla...
Saved in:
| Published in | BMC nephrology Vol. 18; no. 1; p. 281 |
|---|---|
| Main Authors | , , , , , , , , , , |
| Format | Journal Article |
| Language | English |
| Published |
England
BioMed Central Ltd
04.09.2017
BioMed Central BMC |
| Subjects | |
| Online Access | Get full text |
Cover
Loading…
| Abstract | Arterial stiffness is an independent predictor of all-cause and cardiovascular mortality in patients with chronic kidney disease (CKD). There are limited prospective data however on progression of arterial stiffness in CKD, including evaluating associations with bone mineral markers such as fibroblast growth factor 23 (FGF23) and soluble α-klotho (sKl).
In this prospective, single-center, observational study, arterial stiffness [measured by pulse wave velocity (PWV)] and hormones influencing mineral homeostasis, including serum FGF23 and sKl, were compared between non-dialysis CKD stages 4/5 and healthy controls at baseline and 12 months (12 m). Abdominal aortic calcification (AAC) was quantitated using lateral lumbar radiography at baseline.
Forty patients with CKD [mean estimated glomerular filtration rate (eGFR) 19.5 ± 6.7 mL/min/1.73m
] and 42 controls (mean eGFR 88.6 ± 12.9 mL/min/1.73m
) completed follow-up. There were no differences in age, gender and body mass index between groups. A significant increase in FGF23 [240.6 (141.9-1129.8) to 396.8 (160.3-997.7) pg/mL, p = 0.001] was observed in the CKD group but serum phosphate, corrected calcium, parathyroid hormone and sKl did not change significantly over 12 m. At baseline, CKD subjects had higher AAC prevalence [83.8% versus (vs.) 43.6%, p = 0.002] and higher aortic PWV [9.7(7.6-11.7) vs. 8.1 (7.2-9.7) m/s, p = 0.047] compared to controls. At 12 m, aortic PWV increased by 1.3 m/s (95% confidence interval, 0.56 to 2.08, p < 0.001) in the CKD cohort, with 30% of subjects showing progression from normal aortic elasticity to stiffening (PWV > 10 m/s). Serum FGF23 was associated with AAC, abnormal PWV and progression of PWV at 12 m.
Arterial stiffness and serum FGF23, both of which are associated with increased cardiovascular risk, increased over one year in individuals with CKD. Additionally, a significant association was found between serum FGF23 and arterial calcification and stiffness. Larger clinical studies and further experimental work are warranted to delineate the temporal relationship as well as the pathological mechanisms linking FGF23 and vascular disease. |
|---|---|
| AbstractList | Arterial stiffness is an independent predictor of all-cause and cardiovascular mortality in patients with chronic kidney disease (CKD). There are limited prospective data however on progression of arterial stiffness in CKD, including evaluating associations with bone mineral markers such as fibroblast growth factor 23 (FGF23) and soluble [alpha]-klotho (sKl). In this prospective, single-center, observational study, arterial stiffness [measured by pulse wave velocity (PWV)] and hormones influencing mineral homeostasis, including serum FGF23 and sKl, were compared between non-dialysis CKD stages 4/5 and healthy controls at baseline and 12 months (12 m). Abdominal aortic calcification (AAC) was quantitated using lateral lumbar radiography at baseline. Forty patients with CKD [mean estimated glomerular filtration rate (eGFR) 19.5 [+ or -] 6.7 mL/min/1.73m.sup.2] and 42 controls (mean eGFR 88.6 [+ or -] 12.9 mL/min/1.73m.sup.2) completed follow-up. There were no differences in age, gender and body mass index between groups. A significant increase in FGF23 [240.6 (141.9-1129.8) to 396.8 (160.3-997.7) pg/mL, p = 0.001] was observed in the CKD group but serum phosphate, corrected calcium, parathyroid hormone and sKl did not change significantly over 12 m. At baseline, CKD subjects had higher AAC prevalence [83.8% versus (vs.) 43.6%, p = 0.002] and higher aortic PWV [9.7(7.6-11.7) vs. 8.1 (7.2-9.7) m/s, p = 0.047] compared to controls. At 12 m, aortic PWV increased by 1.3 m/s (95% confidence interval, 0.56 to 2.08, p < 0.001) in the CKD cohort, with 30% of subjects showing progression from normal aortic elasticity to stiffening (PWV > 10 m/s). Serum FGF23 was associated with AAC, abnormal PWV and progression of PWV at 12 m. Arterial stiffness and serum FGF23, both of which are associated with increased cardiovascular risk, increased over one year in individuals with CKD. Additionally, a significant association was found between serum FGF23 and arterial calcification and stiffness. Larger clinical studies and further experimental work are warranted to delineate the temporal relationship as well as the pathological mechanisms linking FGF23 and vascular disease. BACKGROUNDArterial stiffness is an independent predictor of all-cause and cardiovascular mortality in patients with chronic kidney disease (CKD). There are limited prospective data however on progression of arterial stiffness in CKD, including evaluating associations with bone mineral markers such as fibroblast growth factor 23 (FGF23) and soluble α-klotho (sKl).METHODSIn this prospective, single-center, observational study, arterial stiffness [measured by pulse wave velocity (PWV)] and hormones influencing mineral homeostasis, including serum FGF23 and sKl, were compared between non-dialysis CKD stages 4/5 and healthy controls at baseline and 12 months (12 m). Abdominal aortic calcification (AAC) was quantitated using lateral lumbar radiography at baseline.RESULTSForty patients with CKD [mean estimated glomerular filtration rate (eGFR) 19.5 ± 6.7 mL/min/1.73m2] and 42 controls (mean eGFR 88.6 ± 12.9 mL/min/1.73m2) completed follow-up. There were no differences in age, gender and body mass index between groups. A significant increase in FGF23 [240.6 (141.9-1129.8) to 396.8 (160.3-997.7) pg/mL, p = 0.001] was observed in the CKD group but serum phosphate, corrected calcium, parathyroid hormone and sKl did not change significantly over 12 m. At baseline, CKD subjects had higher AAC prevalence [83.8% versus (vs.) 43.6%, p = 0.002] and higher aortic PWV [9.7(7.6-11.7) vs. 8.1 (7.2-9.7) m/s, p = 0.047] compared to controls. At 12 m, aortic PWV increased by 1.3 m/s (95% confidence interval, 0.56 to 2.08, p < 0.001) in the CKD cohort, with 30% of subjects showing progression from normal aortic elasticity to stiffening (PWV > 10 m/s). Serum FGF23 was associated with AAC, abnormal PWV and progression of PWV at 12 m.CONCLUSIONSArterial stiffness and serum FGF23, both of which are associated with increased cardiovascular risk, increased over one year in individuals with CKD. Additionally, a significant association was found between serum FGF23 and arterial calcification and stiffness. Larger clinical studies and further experimental work are warranted to delineate the temporal relationship as well as the pathological mechanisms linking FGF23 and vascular disease. Arterial stiffness is an independent predictor of all-cause and cardiovascular mortality in patients with chronic kidney disease (CKD). There are limited prospective data however on progression of arterial stiffness in CKD, including evaluating associations with bone mineral markers such as fibroblast growth factor 23 (FGF23) and soluble α-klotho (sKl). In this prospective, single-center, observational study, arterial stiffness [measured by pulse wave velocity (PWV)] and hormones influencing mineral homeostasis, including serum FGF23 and sKl, were compared between non-dialysis CKD stages 4/5 and healthy controls at baseline and 12 months (12 m). Abdominal aortic calcification (AAC) was quantitated using lateral lumbar radiography at baseline. Forty patients with CKD [mean estimated glomerular filtration rate (eGFR) 19.5 ± 6.7 mL/min/1.73m ] and 42 controls (mean eGFR 88.6 ± 12.9 mL/min/1.73m ) completed follow-up. There were no differences in age, gender and body mass index between groups. A significant increase in FGF23 [240.6 (141.9-1129.8) to 396.8 (160.3-997.7) pg/mL, p = 0.001] was observed in the CKD group but serum phosphate, corrected calcium, parathyroid hormone and sKl did not change significantly over 12 m. At baseline, CKD subjects had higher AAC prevalence [83.8% versus (vs.) 43.6%, p = 0.002] and higher aortic PWV [9.7(7.6-11.7) vs. 8.1 (7.2-9.7) m/s, p = 0.047] compared to controls. At 12 m, aortic PWV increased by 1.3 m/s (95% confidence interval, 0.56 to 2.08, p < 0.001) in the CKD cohort, with 30% of subjects showing progression from normal aortic elasticity to stiffening (PWV > 10 m/s). Serum FGF23 was associated with AAC, abnormal PWV and progression of PWV at 12 m. Arterial stiffness and serum FGF23, both of which are associated with increased cardiovascular risk, increased over one year in individuals with CKD. Additionally, a significant association was found between serum FGF23 and arterial calcification and stiffness. Larger clinical studies and further experimental work are warranted to delineate the temporal relationship as well as the pathological mechanisms linking FGF23 and vascular disease. Background Arterial stiffness is an independent predictor of all-cause and cardiovascular mortality in patients with chronic kidney disease (CKD). There are limited prospective data however on progression of arterial stiffness in CKD, including evaluating associations with bone mineral markers such as fibroblast growth factor 23 (FGF23) and soluble α-klotho (sKl). Methods In this prospective, single-center, observational study, arterial stiffness [measured by pulse wave velocity (PWV)] and hormones influencing mineral homeostasis, including serum FGF23 and sKl, were compared between non-dialysis CKD stages 4/5 and healthy controls at baseline and 12 months (12 m). Abdominal aortic calcification (AAC) was quantitated using lateral lumbar radiography at baseline. Results Forty patients with CKD [mean estimated glomerular filtration rate (eGFR) 19.5 ± 6.7 mL/min/1.73m2] and 42 controls (mean eGFR 88.6 ± 12.9 mL/min/1.73m2) completed follow-up. There were no differences in age, gender and body mass index between groups. A significant increase in FGF23 [240.6 (141.9-1129.8) to 396.8 (160.3-997.7) pg/mL, p = 0.001] was observed in the CKD group but serum phosphate, corrected calcium, parathyroid hormone and sKl did not change significantly over 12 m. At baseline, CKD subjects had higher AAC prevalence [83.8% versus (vs.) 43.6%, p = 0.002] and higher aortic PWV [9.7(7.6-11.7) vs. 8.1 (7.2-9.7) m/s, p = 0.047] compared to controls. At 12 m, aortic PWV increased by 1.3 m/s (95% confidence interval, 0.56 to 2.08, p < 0.001) in the CKD cohort, with 30% of subjects showing progression from normal aortic elasticity to stiffening (PWV > 10 m/s). Serum FGF23 was associated with AAC, abnormal PWV and progression of PWV at 12 m. Conclusions Arterial stiffness and serum FGF23, both of which are associated with increased cardiovascular risk, increased over one year in individuals with CKD. Additionally, a significant association was found between serum FGF23 and arterial calcification and stiffness. Larger clinical studies and further experimental work are warranted to delineate the temporal relationship as well as the pathological mechanisms linking FGF23 and vascular disease. Background Arterial stiffness is an independent predictor of all-cause and cardiovascular mortality in patients with chronic kidney disease (CKD). There are limited prospective data however on progression of arterial stiffness in CKD, including evaluating associations with bone mineral markers such as fibroblast growth factor 23 (FGF23) and soluble [alpha]-klotho (sKl). Methods In this prospective, single-center, observational study, arterial stiffness [measured by pulse wave velocity (PWV)] and hormones influencing mineral homeostasis, including serum FGF23 and sKl, were compared between non-dialysis CKD stages 4/5 and healthy controls at baseline and 12 months (12 m). Abdominal aortic calcification (AAC) was quantitated using lateral lumbar radiography at baseline. Results Forty patients with CKD [mean estimated glomerular filtration rate (eGFR) 19.5 [+ or -] 6.7 mL/min/1.73m.sup.2] and 42 controls (mean eGFR 88.6 [+ or -] 12.9 mL/min/1.73m.sup.2) completed follow-up. There were no differences in age, gender and body mass index between groups. A significant increase in FGF23 [240.6 (141.9-1129.8) to 396.8 (160.3-997.7) pg/mL, p = 0.001] was observed in the CKD group but serum phosphate, corrected calcium, parathyroid hormone and sKl did not change significantly over 12 m. At baseline, CKD subjects had higher AAC prevalence [83.8% versus (vs.) 43.6%, p = 0.002] and higher aortic PWV [9.7(7.6-11.7) vs. 8.1 (7.2-9.7) m/s, p = 0.047] compared to controls. At 12 m, aortic PWV increased by 1.3 m/s (95% confidence interval, 0.56 to 2.08, p < 0.001) in the CKD cohort, with 30% of subjects showing progression from normal aortic elasticity to stiffening (PWV > 10 m/s). Serum FGF23 was associated with AAC, abnormal PWV and progression of PWV at 12 m. Conclusions Arterial stiffness and serum FGF23, both of which are associated with increased cardiovascular risk, increased over one year in individuals with CKD. Additionally, a significant association was found between serum FGF23 and arterial calcification and stiffness. Larger clinical studies and further experimental work are warranted to delineate the temporal relationship as well as the pathological mechanisms linking FGF23 and vascular disease. Keywords: Aortic calcification, Arterial stiffness, Chronic kidney disease, Fibroblast growth factor 23, Soluble klotho Abstract Background Arterial stiffness is an independent predictor of all-cause and cardiovascular mortality in patients with chronic kidney disease (CKD). There are limited prospective data however on progression of arterial stiffness in CKD, including evaluating associations with bone mineral markers such as fibroblast growth factor 23 (FGF23) and soluble α-klotho (sKl). Methods In this prospective, single-center, observational study, arterial stiffness [measured by pulse wave velocity (PWV)] and hormones influencing mineral homeostasis, including serum FGF23 and sKl, were compared between non-dialysis CKD stages 4/5 and healthy controls at baseline and 12 months (12 m). Abdominal aortic calcification (AAC) was quantitated using lateral lumbar radiography at baseline. Results Forty patients with CKD [mean estimated glomerular filtration rate (eGFR) 19.5 ± 6.7 mL/min/1.73m2] and 42 controls (mean eGFR 88.6 ± 12.9 mL/min/1.73m2) completed follow-up. There were no differences in age, gender and body mass index between groups. A significant increase in FGF23 [240.6 (141.9–1129.8) to 396.8 (160.3–997.7) pg/mL, p = 0.001] was observed in the CKD group but serum phosphate, corrected calcium, parathyroid hormone and sKl did not change significantly over 12 m. At baseline, CKD subjects had higher AAC prevalence [83.8% versus (vs.) 43.6%, p = 0.002] and higher aortic PWV [9.7(7.6–11.7) vs. 8.1 (7.2–9.7) m/s, p = 0.047] compared to controls. At 12 m, aortic PWV increased by 1.3 m/s (95% confidence interval, 0.56 to 2.08, p < 0.001) in the CKD cohort, with 30% of subjects showing progression from normal aortic elasticity to stiffening (PWV > 10 m/s). Serum FGF23 was associated with AAC, abnormal PWV and progression of PWV at 12 m. Conclusions Arterial stiffness and serum FGF23, both of which are associated with increased cardiovascular risk, increased over one year in individuals with CKD. Additionally, a significant association was found between serum FGF23 and arterial calcification and stiffness. Larger clinical studies and further experimental work are warranted to delineate the temporal relationship as well as the pathological mechanisms linking FGF23 and vascular disease. |
| ArticleNumber | 281 |
| Audience | Academic |
| Author | Krishnasamy, Rathika Lee, Kevin Isbel, Nicole M Tan, Sven-Jean Hawley, Carmel M Toussaint, Nigel D Stanton, Tony Mudge, David W Campbell, Scott Elder, Grahame J Johnson, David W |
| Author_xml | – sequence: 1 givenname: Rathika orcidid: 0000-0001-6974-7880 surname: Krishnasamy fullname: Krishnasamy, Rathika email: Rathika.Krishnasamy@health.qld.gov.au, Rathika.Krishnasamy@health.qld.gov.au organization: Faculty of Medicine, The University of Queensland, Brisbane, Australia. Rathika.Krishnasamy@health.qld.gov.au – sequence: 2 givenname: Sven-Jean surname: Tan fullname: Tan, Sven-Jean organization: Department of Medicine (RMH), The University of Melbourne, Parkville, VIC, Australia – sequence: 3 givenname: Carmel M surname: Hawley fullname: Hawley, Carmel M organization: Department of Nephrology, Princess Alexandra Hospital, Brisbane, Australia – sequence: 4 givenname: David W surname: Johnson fullname: Johnson, David W organization: Department of Nephrology, Princess Alexandra Hospital, Brisbane, Australia – sequence: 5 givenname: Tony surname: Stanton fullname: Stanton, Tony organization: Department of Cardiology, Sunshine Coast University Hospital, Birtinya, Australia – sequence: 6 givenname: Kevin surname: Lee fullname: Lee, Kevin organization: Department of Radiology, Princess Alexandra Hospital, Brisbane, Australia – sequence: 7 givenname: David W surname: Mudge fullname: Mudge, David W organization: Department of Nephrology, Princess Alexandra Hospital, Brisbane, Australia – sequence: 8 givenname: Scott surname: Campbell fullname: Campbell, Scott organization: Department of Nephrology, Princess Alexandra Hospital, Brisbane, Australia – sequence: 9 givenname: Grahame J surname: Elder fullname: Elder, Grahame J organization: Osteoporosis and Bone Biology Division, Garvan Institute of Medical Research, Sydney, Australia – sequence: 10 givenname: Nigel D surname: Toussaint fullname: Toussaint, Nigel D organization: Department of Medicine (RMH), The University of Melbourne, Parkville, VIC, Australia – sequence: 11 givenname: Nicole M surname: Isbel fullname: Isbel, Nicole M organization: Department of Nephrology, Princess Alexandra Hospital, Brisbane, Australia |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/28870151$$D View this record in MEDLINE/PubMed |
| BookMark | eNptUstuFDEQHKEg8oAP4IJG4sJlgnvGr7kgRcsrIhIc4Gx57J5dL7t2sGeD-Ht6siFkEfLBVndV2V2u0-oopohV9RzYOYCWrwu0WrcNA9UwxUTDH1UnwBU0bSf7owfn4-q0lDUjoObsSXVMNMVAwEnlv-S0zFhKSLFOY23zhDnYTV2mMI6RGnUotS0luWAn9PXPMK1qt7JxidSK9UBPqrchYibS1ubvmG_r1t_Y6Iiw-PT2afV4tJuCz-72s-rb-3dfFx-bq88fLhcXV40Tkk0NCt1pP3gtpcJWWctlK61G149c8Y7bViB6KZQGbLHrBfjOsVE6kOCgl91ZdbnX9cmuzXUO9J5fJtlgbgspLw3NF9wGjRuUahWAH9uBQ6-1G7iXWgjyjDs1a73Za13vhi16h3GiCQ9EDzsxrMwy3RghyGM2C7y6E8jpxw7LZLahONxsbMS0Kwb6Tmj6RQEEffkPdJ12OZJVhOKi7cmY_i9qaWmAEMdE97pZ1FwI1gP0qlOEOv8PipbHbXD0WWOg-gEB9gSXUykZx_sZgZk5ZmYfM0PpMXPMDCfOi4fm3DP-5Kr7DcmNzYA |
| CitedBy_id | crossref_primary_10_4103_tcmj_tcmj_36_20 crossref_primary_10_1016_j_jacc_2019_12_039 crossref_primary_10_1016_j_xkme_2021_10_002 crossref_primary_10_17650_1818_8338_2023_17_1_K675 crossref_primary_10_4070_kcj_2021_0995 crossref_primary_10_3390_jcm9061806 crossref_primary_10_3389_fphar_2022_931746 crossref_primary_10_34067_KID_0006472022 crossref_primary_10_1038_s41598_024_56377_8 crossref_primary_10_3389_fphys_2021_711904 crossref_primary_10_1016_j_cca_2020_02_014 crossref_primary_10_1007_s00198_018_4598_2 crossref_primary_10_1093_ndt_gfac220 crossref_primary_10_1093_ckj_sfad112 crossref_primary_10_1002_jcp_31021 crossref_primary_10_1186_s12882_022_02955_9 crossref_primary_10_1093_mtomcs_mfad009 crossref_primary_10_1038_s41598_024_54812_4 crossref_primary_10_38109_2225_1685_2018_4_64_78 crossref_primary_10_1053_j_ajkd_2023_04_003 crossref_primary_10_3390_jcm12010222 crossref_primary_10_1172_jci_insight_164221 crossref_primary_10_1042_CS20190895 crossref_primary_10_1155_2019_9189362 crossref_primary_10_1681_nsap_2020_19_3_5 |
| Cites_doi | 10.1097/01.ASN.0000145894.57533.C4 10.1006/bbrc.1998.8943 10.1681/ASN.2005101085 10.1016/j.jacc.2009.02.047 10.1016/j.bbrc.2005.11.094 10.1152/ajpendo.00264.2014 10.1186/1471-2369-14-241 10.1681/ASN.2007010068 10.1046/j.1523-1755.2002.00170.x 10.1371/journal.pone.0056695 10.1371/journal.pone.0044161 10.1046/j.1523-1755.2002.00625.x 10.1681/ASN.2006070783 10.1093/ndt/gfq293 10.1038/ki.2009.24 10.1038/ki.2013.332 10.1038/ki.2013.3 10.1177/0004563213510708 10.1016/j.jacc.2009.10.061 10.1111/jch.12198 10.1172/JCI61405 10.1006/bbrc.2000.4226 10.1159/000331737 10.1038/sj.ki.5001589 10.1111/j.1474-9726.2012.00796.x 10.1016/S0021-9150(97)00106-8 10.1681/ASN.2009121311 10.1249/mss.0b013e3180616aa2 10.1093/ndt/gfl718 10.1161/HYPERTENSIONAHA.112.197210 10.1159/000353593 10.1161/01.HYP.33.5.1111 10.1172/JCI46122 10.1111/nep.12268 10.1172/JCI200419081 10.1136/heartjnl-2013-304746 10.1152/ajpendo.00596.2012 10.1097/HJH.0b013e32834fa8b0 10.1038/36285 10.7326/0003-4819-150-9-200905050-00006 10.1007/s00198-011-1838-0 10.1016/j.atherosclerosis.2009.01.001 10.1161/01.CIR.99.18.2434 10.1074/jbc.M304544200 |
| ContentType | Journal Article |
| Copyright | COPYRIGHT 2017 BioMed Central Ltd. Copyright BioMed Central 2017 The Author(s). 2017 |
| Copyright_xml | – notice: COPYRIGHT 2017 BioMed Central Ltd. – notice: Copyright BioMed Central 2017 – notice: The Author(s). 2017 |
| DBID | CGR CUY CVF ECM EIF NPM AAYXX CITATION 3V. 7QP 7X7 7XB 88E 8FI 8FJ 8FK ABUWG AFKRA AZQEC BENPR CCPQU DWQXO FYUFA GHDGH K9. M0S M1P PIMPY PQEST PQQKQ PQUKI PRINS 7X8 5PM DOA |
| DOI | 10.1186/s12882-017-0705-4 |
| DatabaseName | Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed CrossRef ProQuest Central (Corporate) Calcium & Calcified Tissue Abstracts Health & Medical Collection ProQuest Central (purchase pre-March 2016) Medical Database (Alumni Edition) Hospital Premium Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) ProQuest Central (Alumni) ProQuest Central ProQuest Central Essentials ProQuest Central ProQuest One Community College ProQuest Central Health Research Premium Collection Health Research Premium Collection (Alumni) ProQuest Health & Medical Complete (Alumni) Health & Medical Collection (Alumni Edition) PML(ProQuest Medical Library) Publicly Available Content Database ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Academic ProQuest One Academic UKI Edition ProQuest Central China MEDLINE - Academic PubMed Central (Full Participant titles) Directory of Open Access Journals |
| DatabaseTitle | MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) CrossRef Publicly Available Content Database ProQuest Central Essentials ProQuest One Academic Eastern Edition ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) ProQuest One Community College ProQuest Hospital Collection Health Research Premium Collection (Alumni) ProQuest Central China ProQuest Hospital Collection (Alumni) ProQuest Central ProQuest Health & Medical Complete Health Research Premium Collection ProQuest Medical Library ProQuest One Academic UKI Edition Health and Medicine Complete (Alumni Edition) ProQuest Central Korea ProQuest One Academic Calcium & Calcified Tissue Abstracts ProQuest Medical Library (Alumni) ProQuest Central (Alumni) MEDLINE - Academic |
| DatabaseTitleList | MEDLINE - Academic MEDLINE Publicly Available Content Database |
| Database_xml | – sequence: 1 dbid: DOA name: DOAJ Directory of Open Access Journals url: https://www.doaj.org/ sourceTypes: Open Website – sequence: 2 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 3 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database – sequence: 4 dbid: 7X7 name: ProQuest - Health & Medical Complete保健、医学与药学数据库 url: https://search.proquest.com/healthcomplete sourceTypes: Aggregation Database |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Medicine |
| EISSN | 1471-2369 |
| EndPage | 281 |
| ExternalDocumentID | oai_doaj_org_article_cb772711df2b41988cb4d68551474c76 A509119737 10_1186_s12882_017_0705_4 28870151 |
| Genre | Journal Article Observational Study |
| GrantInformation_xml | – fundername: ; |
| GroupedDBID | --- -A0 0R~ 23N 2WC 3V. 53G 5GY 5VS 6J9 6PF 7X7 88E 8FI 8FJ AAFWJ AAJSJ AAWTL ABUWG ACGFO ACGFS ACIHN ACPRK ACRMQ ADBBV ADINQ ADRAZ ADUKV AEAQA AENEX AFKRA AFPKN AHBYD AHMBA AHYZX ALIPV ALMA_UNASSIGNED_HOLDINGS AMKLP AMTXH AOIJS BAPOH BAWUL BCNDV BENPR BFQNJ BMC BPHCQ BVXVI C24 C6C CCPQU CGR CS3 CUY CVF DIK DU5 E3Z EBD EBLON EBS ECM EIF EJD EMB EMOBN F5P FYUFA GROUPED_DOAJ GX1 H13 HMCUK HYE IAO IHR INH INR ITC KQ8 M1P M48 M~E NPM O5R O5S OK1 P2P PGMZT PIMPY PQQKQ PROAC PSQYO RBZ RNS ROL RPM RSV SMD SOJ SV3 TR2 UKHRP W2D WOQ WOW XSB AAYXX CITATION 7QP 7XB 8FK AHSBF AZQEC DWQXO K9. PQEST PQUKI PRINS 7X8 5PM |
| ID | FETCH-LOGICAL-c560t-e5838dbd8667e27aa4626a8ec9f47434a25eed65781e2e3951d3c0f6c161c1963 |
| IEDL.DBID | RPM |
| ISSN | 1471-2369 |
| IngestDate | Tue Oct 22 15:08:32 EDT 2024 Tue Sep 17 20:49:41 EDT 2024 Fri Oct 25 01:27:33 EDT 2024 Thu Oct 10 20:01:49 EDT 2024 Tue Nov 19 21:06:29 EST 2024 Tue Nov 12 23:05:49 EST 2024 Thu Sep 12 17:48:41 EDT 2024 Sat Sep 28 08:46:32 EDT 2024 |
| IsDoiOpenAccess | true |
| IsOpenAccess | true |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 1 |
| Keywords | Soluble klotho Chronic kidney disease Aortic calcification Arterial stiffness Fibroblast growth factor 23 |
| Language | English |
| License | Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-c560t-e5838dbd8667e27aa4626a8ec9f47434a25eed65781e2e3951d3c0f6c161c1963 |
| Notes | ObjectType-Article-2 SourceType-Scholarly Journals-1 ObjectType-Undefined-1 ObjectType-Feature-3 content type line 23 |
| ORCID | 0000-0001-6974-7880 |
| OpenAccessLink | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5584006/ |
| PMID | 28870151 |
| PQID | 1945295839 |
| PQPubID | 44769 |
| PageCount | 1 |
| ParticipantIDs | doaj_primary_oai_doaj_org_article_cb772711df2b41988cb4d68551474c76 pubmedcentral_primary_oai_pubmedcentral_nih_gov_5584006 proquest_miscellaneous_1935818651 proquest_journals_1945295839 gale_infotracmisc_A509119737 gale_infotracacademiconefile_A509119737 crossref_primary_10_1186_s12882_017_0705_4 pubmed_primary_28870151 |
| PublicationCentury | 2000 |
| PublicationDate | 2017-09-04 |
| PublicationDateYYYYMMDD | 2017-09-04 |
| PublicationDate_xml | – month: 09 year: 2017 text: 2017-09-04 day: 04 |
| PublicationDecade | 2010 |
| PublicationPlace | England |
| PublicationPlace_xml | – name: England – name: London |
| PublicationTitle | BMC nephrology |
| PublicationTitleAlternate | BMC Nephrol |
| PublicationYear | 2017 |
| Publisher | BioMed Central Ltd BioMed Central BMC |
| Publisher_xml | – name: BioMed Central Ltd – name: BioMed Central – name: BMC |
| References | 17494882 - J Am Soc Nephrol. 2007 Jun;18(6):1637-47 16325773 - Biochem Biophys Res Commun. 2006 Jan 20;339(3):827-32 17205962 - Nephrol Dial Transplant. 2007 Apr;22(4):1171-6 24088960 - Kidney Int. 2014 May;85(5):1103-11 23431388 - PLoS One. 2013;8(2):e56695 20501463 - Nephrol Dial Transplant. 2010 Dec;25(12):4041-8 9675134 - Biochem Biophys Res Commun. 1998 Jul 20;248(2):324-9 22970174 - PLoS One. 2012;7(9):e44161 20338492 - J Am Coll Cardiol. 2010 Mar 30;55(13):1318-27 24269946 - Ann Clin Biochem. 2014 Mar;51(Pt 2):203-27 24750549 - Nephrology (Carlton). 2014 Aug;19(8):439-49 12371973 - Kidney Int. 2002 Nov;62(5):1724-31 21115613 - J Am Soc Nephrol. 2011 Jan;22(1):124-36 19181315 - Atherosclerosis. 2009 Aug;205(2):385-90 23090769 - Hypertension. 2012 Dec;60(6):1451-7 11162628 - Biochem Biophys Res Commun. 2001 Feb 2;280(4):1015-20 19414839 - Ann Intern Med. 2009 May 5;150(9):604-12 19497438 - J Am Coll Cardiol. 2009 Jun 9;53(23):2129-40 14966565 - J Clin Invest. 2004 Feb;113(4):561-8 21985788 - J Clin Invest. 2011 Nov;121(11):4393-408 16738019 - J Am Soc Nephrol. 2006 Jul;17(7):2034-47 9242971 - Atherosclerosis. 1997 Jul 25;132(2):245-50 22728934 - J Clin Invest. 2012 Jul;122(7):2543-53 21865732 - Cell Physiol Biochem. 2011;28(2):251-8 24102750 - J Clin Hypertens (Greenwich). 2013 Nov;15(11):833-8 25053401 - Am J Physiol Endocrinol Metab. 2014 Sep 1;307(5):E426-36 24180481 - BMC Nephrol. 2013 Nov 01;14:241 17762378 - Med Sci Sports Exerc. 2007 Aug;39(8):1435-45 17855636 - J Am Soc Nephrol. 2007 Oct;18(10):2683-8 10334796 - Hypertension. 1999 May;33(5):1111-7 22278144 - J Hypertens. 2012 Mar;30(3):445-8 24165855 - Heart. 2014 Jan;100(1):34-40 23443925 - Am J Physiol Endocrinol Metab. 2013 Apr 15;304(8):E863-73 23389416 - Kidney Int. 2013 Jun;83(6):1159-68 15579497 - J Am Soc Nephrol. 2004 Dec;15(12):2959-64 9363890 - Nature. 1997 Nov 6;390(6655):45-51 19225558 - Kidney Int. 2009 Jun;75(11):1166-72 11849407 - Kidney Int. 2002 Feb;61(2):638-47 12874285 - J Biol Chem. 2003 Sep 26;278(39):37419-26 16775593 - Kidney Int. 2006 Aug;70(3):543-8 22260450 - Aging Cell. 2012 Jun;11(3):410-7 23942553 - Nephron Clin Pract. 2013;123(3-4):194-201 22109743 - Osteoporos Int. 2012 Jul;23(7):2017-25 10318666 - Circulation. 1999 May 11;99(18):2434-9 CM Giachelli (705_CR5) 2004; 15 A Karras (705_CR4) 2012; 60 N Koh (705_CR13) 2001; 280 MA Mirza (705_CR28) 2009; 205 T Shimada (705_CR11) 2004; 113 J Blacher (705_CR21) 1999; 33 JP Schwaiger (705_CR2) 2006; 70 SM Moe (705_CR7) 2002; 61 ME Nelson (705_CR19) 2007; 39 LI Kauppila (705_CR23) 1997; 132 Y Saito (705_CR42) 1998; 248 ER Smith (705_CR40) 2014; 51 B Dai (705_CR39) 2012; 7 C Faul (705_CR36) 2011; 121 LM Bortel Van (705_CR22) 2012; 30 MC Hu (705_CR43) 2011; 22 Y Wang (705_CR41) 2012; 11 R Jimbo (705_CR17) 2014; 85 M Dermaku-Sopjani (705_CR15) 2011; 28 M Ikushima (705_CR16) 2006; 339 L Desjardins (705_CR30) 2012; 23 JF Navarro-Gonzalez (705_CR44) 2014; 100 AS Levey (705_CR20) 2009; 150 M Kitagawa (705_CR45) 2013; 8 L Craver (705_CR12) 2007; 22 SJ Tan (705_CR14) 2014; 19 S Liu (705_CR8) 2003; 278 JJ Scialla (705_CR29) 2013; 83 M Kuro-o (705_CR33) 1997; 390 M Ohnishi (705_CR32) 2009; 75 S Tholen (705_CR27) 2013; 15 N Silswal (705_CR34) 2014; 307 T Kawata (705_CR10) 2007; 18 M Tonelli (705_CR1) 2006; 17 C Vlachopoulos (705_CR24) 2010; 55 J Blacher (705_CR25) 1999; 99 CD Touchberry (705_CR35) 2013; 304 FG Hage (705_CR3) 2009; 53 A Ozkok (705_CR31) 2013; 14 JY Jung (705_CR26) 2010; 25 S Liu (705_CR9) 2007; 18 NX Chen (705_CR6) 2002; 62 Welfare AIoHa (705_CR18) 2003 V Shalhoub (705_CR37) 2012; 122 CP Kovesdy (705_CR38) 2013; 123 |
| References_xml | – volume: 15 start-page: 2959 issue: 12 year: 2004 ident: 705_CR5 publication-title: Journal of the American Society of Nephrology : JASN doi: 10.1097/01.ASN.0000145894.57533.C4 contributor: fullname: CM Giachelli – volume: 248 start-page: 324 issue: 2 year: 1998 ident: 705_CR42 publication-title: Biochem Biophys Res Commun doi: 10.1006/bbrc.1998.8943 contributor: fullname: Y Saito – volume: 17 start-page: 2034 issue: 7 year: 2006 ident: 705_CR1 publication-title: J Am Soc Nephrol doi: 10.1681/ASN.2005101085 contributor: fullname: M Tonelli – volume: 53 start-page: 2129 issue: 23 year: 2009 ident: 705_CR3 publication-title: J Am Coll Cardiol doi: 10.1016/j.jacc.2009.02.047 contributor: fullname: FG Hage – volume: 339 start-page: 827 issue: 3 year: 2006 ident: 705_CR16 publication-title: Biochem Biophys Res Commun doi: 10.1016/j.bbrc.2005.11.094 contributor: fullname: M Ikushima – volume: 307 start-page: E426 issue: 5 year: 2014 ident: 705_CR34 publication-title: Am J Phys Endocrinol Metab doi: 10.1152/ajpendo.00264.2014 contributor: fullname: N Silswal – volume: 14 start-page: 241 year: 2013 ident: 705_CR31 publication-title: BMC Nephrol doi: 10.1186/1471-2369-14-241 contributor: fullname: A Ozkok – volume: 18 start-page: 1637 issue: 6 year: 2007 ident: 705_CR9 publication-title: J Am Soc Nephrol doi: 10.1681/ASN.2007010068 contributor: fullname: S Liu – volume: 61 start-page: 638 issue: 2 year: 2002 ident: 705_CR7 publication-title: Kidney Int doi: 10.1046/j.1523-1755.2002.00170.x contributor: fullname: SM Moe – volume: 8 issue: 2 year: 2013 ident: 705_CR45 publication-title: PLoS One doi: 10.1371/journal.pone.0056695 contributor: fullname: M Kitagawa – volume: 7 issue: 9 year: 2012 ident: 705_CR39 publication-title: PLoS One doi: 10.1371/journal.pone.0044161 contributor: fullname: B Dai – volume: 62 start-page: 1724 issue: 5 year: 2002 ident: 705_CR6 publication-title: Kidney Int doi: 10.1046/j.1523-1755.2002.00625.x contributor: fullname: NX Chen – volume: 18 start-page: 2683 issue: 10 year: 2007 ident: 705_CR10 publication-title: J Am Soc Nephrol doi: 10.1681/ASN.2006070783 contributor: fullname: T Kawata – volume: 25 start-page: 4041 issue: 12 year: 2010 ident: 705_CR26 publication-title: Nephrol Dial Transplant doi: 10.1093/ndt/gfq293 contributor: fullname: JY Jung – volume: 75 start-page: 1166 issue: 11 year: 2009 ident: 705_CR32 publication-title: Kidney Int doi: 10.1038/ki.2009.24 contributor: fullname: M Ohnishi – volume: 85 start-page: 1103 issue: 5 year: 2014 ident: 705_CR17 publication-title: Kidney Int doi: 10.1038/ki.2013.332 contributor: fullname: R Jimbo – volume: 83 start-page: 1159 issue: 6 year: 2013 ident: 705_CR29 publication-title: Kidney Int doi: 10.1038/ki.2013.3 contributor: fullname: JJ Scialla – volume: 51 start-page: 203 issue: Pt 2 year: 2014 ident: 705_CR40 publication-title: Ann Clin Biochem doi: 10.1177/0004563213510708 contributor: fullname: ER Smith – volume: 55 start-page: 1318 issue: 13 year: 2010 ident: 705_CR24 publication-title: J Am Coll Cardiol doi: 10.1016/j.jacc.2009.10.061 contributor: fullname: C Vlachopoulos – volume: 15 start-page: 833 issue: 11 year: 2013 ident: 705_CR27 publication-title: J Clin Hypertens doi: 10.1111/jch.12198 contributor: fullname: S Tholen – volume: 122 start-page: 2543 issue: 7 year: 2012 ident: 705_CR37 publication-title: J Clin Invest doi: 10.1172/JCI61405 contributor: fullname: V Shalhoub – volume: 280 start-page: 1015 issue: 4 year: 2001 ident: 705_CR13 publication-title: Biochem Biophys Res Commun doi: 10.1006/bbrc.2000.4226 contributor: fullname: N Koh – volume: 28 start-page: 251 issue: 2 year: 2011 ident: 705_CR15 publication-title: Cell Physiol Biochem doi: 10.1159/000331737 contributor: fullname: M Dermaku-Sopjani – volume: 70 start-page: 543 issue: 3 year: 2006 ident: 705_CR2 publication-title: Kidney Int doi: 10.1038/sj.ki.5001589 contributor: fullname: JP Schwaiger – volume: 11 start-page: 410 issue: 3 year: 2012 ident: 705_CR41 publication-title: Aging Cell doi: 10.1111/j.1474-9726.2012.00796.x contributor: fullname: Y Wang – volume: 132 start-page: 245 issue: 2 year: 1997 ident: 705_CR23 publication-title: Atherosclerosis doi: 10.1016/S0021-9150(97)00106-8 contributor: fullname: LI Kauppila – volume: 22 start-page: 124 issue: 1 year: 2011 ident: 705_CR43 publication-title: Journal of the American Society of Nephrology : JASN doi: 10.1681/ASN.2009121311 contributor: fullname: MC Hu – volume: 39 start-page: 1435 issue: 8 year: 2007 ident: 705_CR19 publication-title: Med Sci Sports Exerc doi: 10.1249/mss.0b013e3180616aa2 contributor: fullname: ME Nelson – volume: 22 start-page: 1171 issue: 4 year: 2007 ident: 705_CR12 publication-title: Nephrol Dial Transplant doi: 10.1093/ndt/gfl718 contributor: fullname: L Craver – volume-title: The active Australia survey: a guide andmanual for implementation, analysis and reporting year: 2003 ident: 705_CR18 contributor: fullname: Welfare AIoHa – volume: 60 start-page: 1451 issue: 6 year: 2012 ident: 705_CR4 publication-title: Hypertension doi: 10.1161/HYPERTENSIONAHA.112.197210 contributor: fullname: A Karras – volume: 123 start-page: 194 issue: 3–4 year: 2013 ident: 705_CR38 publication-title: Nephron Clinical practice doi: 10.1159/000353593 contributor: fullname: CP Kovesdy – volume: 33 start-page: 1111 issue: 5 year: 1999 ident: 705_CR21 publication-title: Hypertension doi: 10.1161/01.HYP.33.5.1111 contributor: fullname: J Blacher – volume: 121 start-page: 4393 issue: 11 year: 2011 ident: 705_CR36 publication-title: J Clin Invest doi: 10.1172/JCI46122 contributor: fullname: C Faul – volume: 19 start-page: 439 issue: 8 year: 2014 ident: 705_CR14 publication-title: Nephrology doi: 10.1111/nep.12268 contributor: fullname: SJ Tan – volume: 113 start-page: 561 issue: 4 year: 2004 ident: 705_CR11 publication-title: J Clin Invest doi: 10.1172/JCI200419081 contributor: fullname: T Shimada – volume: 100 start-page: 34 issue: 1 year: 2014 ident: 705_CR44 publication-title: Heart doi: 10.1136/heartjnl-2013-304746 contributor: fullname: JF Navarro-Gonzalez – volume: 304 start-page: E863 issue: 8 year: 2013 ident: 705_CR35 publication-title: Am J Phys Endocrinol Metab doi: 10.1152/ajpendo.00596.2012 contributor: fullname: CD Touchberry – volume: 30 start-page: 445 issue: 3 year: 2012 ident: 705_CR22 publication-title: J Hypertens doi: 10.1097/HJH.0b013e32834fa8b0 contributor: fullname: LM Bortel Van – volume: 390 start-page: 45 issue: 6655 year: 1997 ident: 705_CR33 publication-title: Nature doi: 10.1038/36285 contributor: fullname: M Kuro-o – volume: 150 start-page: 604 issue: 9 year: 2009 ident: 705_CR20 publication-title: Ann Intern Med doi: 10.7326/0003-4819-150-9-200905050-00006 contributor: fullname: AS Levey – volume: 23 start-page: 2017 issue: 7 year: 2012 ident: 705_CR30 publication-title: Osteoporos Int doi: 10.1007/s00198-011-1838-0 contributor: fullname: L Desjardins – volume: 205 start-page: 385 issue: 2 year: 2009 ident: 705_CR28 publication-title: Atherosclerosis doi: 10.1016/j.atherosclerosis.2009.01.001 contributor: fullname: MA Mirza – volume: 99 start-page: 2434 issue: 18 year: 1999 ident: 705_CR25 publication-title: Circulation doi: 10.1161/01.CIR.99.18.2434 contributor: fullname: J Blacher – volume: 278 start-page: 37419 issue: 39 year: 2003 ident: 705_CR8 publication-title: J Biol Chem doi: 10.1074/jbc.M304544200 contributor: fullname: S Liu |
| SSID | ssj0017840 |
| Score | 2.294656 |
| Snippet | Arterial stiffness is an independent predictor of all-cause and cardiovascular mortality in patients with chronic kidney disease (CKD). There are limited... Background Arterial stiffness is an independent predictor of all-cause and cardiovascular mortality in patients with chronic kidney disease (CKD). There are... BACKGROUNDArterial stiffness is an independent predictor of all-cause and cardiovascular mortality in patients with chronic kidney disease (CKD). There are... Abstract Background Arterial stiffness is an independent predictor of all-cause and cardiovascular mortality in patients with chronic kidney disease (CKD).... |
| SourceID | doaj pubmedcentral proquest gale crossref pubmed |
| SourceType | Open Website Open Access Repository Aggregation Database Index Database |
| StartPage | 281 |
| SubjectTerms | Aged Aorta Aortic calcification Arterial stiffness Arteriosclerosis Atherosclerosis Biomarkers - blood Body mass Body mass index Bone Density - physiology Calcification Calcification (ectopic) Calcium phosphates Cardiovascular disease Cardiovascular diseases Chronic kidney disease Chronic kidney failure Coronary vessels Development and progression Dialysis Disease Progression Epidermal growth factor receptors Female Fibroblast growth factor 23 Fibroblast growth factors Fibroblast Growth Factors - blood Fibroblasts Follow-Up Studies Glomerular filtration rate Glomerular Filtration Rate - physiology Growth factors Homeostasis Humans Ischemia Kidney diseases Kidney transplantation Klotho protein Laboratories Longitudinal Studies Male Metabolism Middle Aged Mortality Nephrology Parathyroid Parathyroid hormone Prospective Studies Proteins Pulse Wave Analysis - methods Radiography Renal Insufficiency, Chronic - blood Renal Insufficiency, Chronic - diagnostic imaging Risk factors Smooth muscle Soluble klotho Urine Vascular Stiffness - physiology |
| SummonAdditionalLinks | – databaseName: Directory of Open Access Journals dbid: DOA link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1Lb9QwELaqHlAvqECBQEFGQqqEFDV2_MqxFKoK1KoHKvVm-RWxh2ZRd_v_mbG9q404cOllDxlHG8_n8cxkxl8I-SwCj4qH1PIQRSsG-BlG6VsuPZM6Jdd7POB8da0ub8WPO3m386kv7Akr9MBFcafBQ_ynGYsj9wIyZBO8iMqgo9ci6EK23fFNMlXrBxryllrDZEadrmAXNtiCgK_lOtmKmRfKZP3_bsk7PmneL7njgC4OyfMaOdKz8sQvyF6aXpJnV7U2_orEG2y1KjQbdDnS3KwJq4uCEY8j7mh0saKuwpEixVewtBz8BdFE_XJK9H6RaajpPbbtPOTrmzYBev7z2xG5vfj-6_yyrd9QaAPEMus2YVk0-miU0olr5wRkMM6kMIygv144LsFLKrBblnjqId6KfehGFSASDGidr8n-BH__llDdO9cl1o2DEUL03CSnuO6Uc15GLV1Dvmx0av8UqgybUwyjbAHAAgAWAbCiIV9R69uByHKdLwD2tmJv_4d9Q04QM4u2CMAEV48UwPMiq5U9w2iIDbrXDTmejQQbCnPxBnVbbXhl2YBFadDf0JBPWzHeiX1pU1o-4hjkjzNKsoa8KYtkOyWYsYZgCyR6tnxmc55LpsXvzPAtISyE7fDdUyjpPTngeeFjEeyY7K8fHtMHCKTW_mO2mb9FYhka priority: 102 providerName: Directory of Open Access Journals – databaseName: ProQuest Central dbid: BENPR link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1La9wwEBbtBkovpe-4SYsKhULBxJL18qkkaUJoSQilgdyEXm73EDvZ3fz_zNjaTUygFx88MrY8r280oxEhX0TgUfGQSh6iKEUDl6aVvuTSM6lTcrXHDc6nZ-rkQvy8lJd5wW2ZyyrXNnEw1LEPuEa-B8E25qTAn3-_vinx1CjMruYjNJ6SLc5qY2Zk6-Do7Pz3Jo-gIX7JuUxm1N4SrLHBUgRcnqtkKSbeaGja_9g0P_BN07rJB47o-CV5kREk3R9Z_oo8Sd1r8uw058jfkHiOJVdjuw3at3Qo2gQpo6DMbYuWjc6X1GW2pEhxKZaOG4CB1FHfd4lezYd21PQKy3cWw_11uQA9_PXjLbk4PvpzeFLmsxTKAJhmVSZMj0YfjVI6ce2cgEjGmRSaVgCIEI5L8JYK9JclnmrAXbEOVasCIMKAWvqOzDp4_TahunauSqxqGyOEqLlJTnFdKee8jFq6gnxb_1N7PbbMsEOoYZQdGWCBARYZYEVBDvCvbwZit-vhRr_4a7Py2OAhBtCMxZZ7wRpjghdRGQR7WgStCvIVeWZRJ4ExweWtBfC92N3K7iMqYo2udUF2JyNBl8KUvOa6zbq8tPeSV5DPGzI-ifVpXepvcQz2kTNKsoK8H4VkMyWYsQbQBRQ9EZ_JnKeUbv5v6PQtAR6CWfzw_8_aIc_5INKY5tols9XiNn0EqLTyn7I-3AEKHRMQ priority: 102 providerName: ProQuest – databaseName: Scholars Portal Journals: Open Access dbid: M48 link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV3di9QwEB_OE8QX8dvqKREEQai2ab76IHKeHoey4oML9xbyVV3wurq7B_rfO5N21yvegy99yKSkycxkftOZTACeicCj4iGVPERRihYfbSd9yaWvpU7JNZ4OOM8-qZO5-HAqT_dge73VuIDrS107uk9qvvr-8tfP329Q4V9nhTfq1Rr3WEMJBvTTrZKluAJXORpGyvCaib9BBY3OzBjYvPS1iWnKFfz_3acvGKppEuUFq3R8E26McJIdDvy_BXupvw3XZmPA_A7Ez5R_NdTeYMuO5QxOFDmGmt11tM2xxZq5kUcpMvovy4bTwEjqmV_2iZ0tcm1qdka5PKvcvs0dYEcf392F-fH7L0cn5XixQhkQ4GzKRLHS6KNRSieunRPo1jiTQtsJRBTCcYmmU6Ey14mnBkFYbELVqYDwMJDK3oP9Hod_AEw3zlWprrrWCCEabpJTXFfKOS-jlq6AF9s1tT-G-hk2-x1G2YEBFhlgiQFWFPCWVn3XkUpf54bl6qsdNckGjw6BruvYcS_q1pjgRVSGkJ8WQasCnhPPLIkMMia48ZwBfi-VurKHBJHqVje6gINJT1SsMCVvuW63cmnrliLVuH5tAU93ZHqTktX6tDynPlRUzihZF3B_EJLdlHDGGhEYUvREfCZznlL6xbdc9lsiVsQ98uF_jPsIrvMs1xT4OoD9zeo8PUbwtPFPskr8Aa5HFps priority: 102 providerName: Scholars Portal |
| Title | Progression of arterial stiffness is associated with changes in bone mineral markers in advanced CKD |
| URI | https://www.ncbi.nlm.nih.gov/pubmed/28870151 https://www.proquest.com/docview/1945295839 https://search.proquest.com/docview/1935818651 https://pubmed.ncbi.nlm.nih.gov/PMC5584006 https://doaj.org/article/cb772711df2b41988cb4d68551474c76 |
| Volume | 18 |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3da9swEBdtB2MvY9_z1gUNBoOBm0jWlx_TrKVkpIRthb4JSZa3wOKUJP3_dyfboWZve5FBJ2FZd6c76X46E_JJBF4pHmLOQyVyUUJR1tLnXHomdYyu8HjBeXGtrm7E_FbeHhHZ34VJoP3gV2fNn_VZs_qdsJV36zDucWLj5WImwWqCtIyPyTGY336L3oUONNC68CUzaryDBdgg-gBP5CYyxx_xQI0GM8gGtiil7P93YX5gmYaoyQdm6PIZedr5j3TajvM5OYrNC_J40UXIX5JqiYCrNtkG3dQ0QTZBxiiocl3jukZXO-o6psSK4kEsba__AqmhftNEul6lZNR0jeCdbarvwQJ09u3rK3JzefFzdpV3f1LIA3g0-zxicLTylVFKR66dE7CPcSaGshbgQgjHJdhKBdrLIo8FeF1VESa1CuAPBtTR1-Skgde_JVQXzk0im9SlEUIU3ESnuJ4o57ystHQZ-dLPqb1rE2bYtNEwyra8sMALi7ywIiPnOOuHhpjrOlVstr9sx3EbPOwANGNVzb1gpTHBi0oZdPW0CFpl5DPyzKJGAmOC6y4WwHgxt5Wdok_ESl3ojJwOWoImhSG557rtNHlnWYmhaZi_MiMfD2Tsiei0Jm7usQ1mkTNKsoy8aYXk8Em9rGVED8Rn8M1DCoh9yvPdifm7_-75njzhSfAx_nVKTvbb-_gBfKi9H4Hm3OoReTSdzn_M4Xl-cb38PkonElAuhBklrfoLgz8gWg |
| link.rule.ids | 230,314,727,780,784,864,885,2102,12056,21388,24318,27924,27925,31719,31720,33744,33745,43310,43805,53791,53793 |
| linkProvider | National Library of Medicine |
| linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3da9RAEF_0CuqL-FmjVVcQBCE02exXnqStLaftHUVa6NuyX9F7aFLvrv-_M8ne2SD4kofMhmQzX7_ZmZ0l5CP3LEjmY8584Dmv4VI3wuVMuFKoGG3lcIPzbC6nl_z7lbhKC26rVFa5sYm9oQ6dxzXyfQi2MScF_vzLze8cT43C7Go6QuM-2cHO6WJCdg6P5-c_tnkEBfFLymWWWu6vwBprLEXA5blC5Hzkjfqm_f-a5ju-aVw3eccRnTwhjxOCpAcDy5-Se7F9Rh7MUo78OQnnWHI1tNugXUP7ok2QMgrK3DRo2ehiRW1iSwwUl2LpsAEYSC11XRvp9aJvR02vsXxn2d_flAvQo9OvL8jlyfHF0TRPZynkHjDNOo-YHg0uaClVZMpaDpGM1dHXDQcQwS0T4C0l6G8ZWawAd4XKF430gAg9aulLMmnh9a8IVZW1RSyLptac84rpaCVThbTWiaCEzcjnzT81N0PLDNOHGlqagQEGGGCQAYZn5BD_-nYgdrvub3TLnyYpj_EOYgBVlqFhjpe11t7xIDWCPcW9khn5hDwzqJPAGG_T1gL4XuxuZQ4QFZW1qlRG9kYjQZf8mLzhukm6vDJ_JS8jH7ZkfBLr09rY3eIY7COnpSgzsjsIyXZKMGMFoAsoaiQ-ozmPKe3iV9_pWwA8BLP4-v-f9Z48nF7MzszZt_npG_KI9eKNKa89Mlkvb-NbgE1r9y7pxh8HqBX4 |
| linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3db9MwELdgSBMviG_CBhgJCQkpa-34K4-joxqMTn1g0t4sx3agEk2rtvv_d-ckVSPeeMmDPxTbd-e78_18JuST8Dwo7mPOfRC5KOFT1rLKuayY1DG6osILzrNrdXkjftzK24OnvhJo31eLs-bv8qxZ_EnYyvXSj3qc2Gg-m0jQmsAto3WoRw_JI1kAk_WOehdA0NCiC2Iyo0Zb2IYNYhDwXG4sc3yOB0o0KEM20Egpcf-_2_OBfhpiJw-U0fQpedJZkfS8He0z8iA2z8nxrIuTvyBhjrCrNuUGXdU0ATeB0ygIdF3j7kYXW-o60sRA8TiWtpeAoaqh1aqJdLlIKanpEiE8m1TeQwbo5OriJbmZfvs1ucy79xRyD3bNLo8YIg1VMErpyLVzArwZZ6IvawGGhHBcgsZUIMMs8liA7RUKP66VB6vQo6S-IkcN_P4NobpwbhzZuC6NEKLgJjrF9Vg5V8mgpcvIl35N7bpNm2GTu2GUbWlhgRYWaWFFRr7iqu8bYsbrVLDa_LYd3a2vwA_QjIWaV4KVxvhKBGXQ4NPCa5WRz0gzi3IJhPGuu14A48UMV_YcLSNW6kJn5HTQEuTJD6t7qttOnreWlRighvUrM_JxX409EaPWxNUdtsFcckZJlpHXLZPsp9TzWkb0gH0Gcx7WAPOnbN8ds7_9754fyPH8Ymp_fr--OiGPeZIBDIidkqPd5i6-A6NqV71P4nMPsvce5g |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Progression+of+arterial+stiffness+is+associated+with+changes+in+bone+mineral+markers+in+advanced+CKD&rft.jtitle=BMC+nephrology&rft.au=Krishnasamy%2C+Rathika&rft.au=Tan%2C+Sven-Jean&rft.au=Hawley%2C+Carmel+M&rft.au=Johnson%2C+David+W&rft.date=2017-09-04&rft.eissn=1471-2369&rft.volume=18&rft.issue=1&rft.spage=281&rft.epage=281&rft_id=info:doi/10.1186%2Fs12882-017-0705-4&rft.externalDBID=NO_FULL_TEXT |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1471-2369&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1471-2369&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1471-2369&client=summon |